BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27279287)

  • 1. 7-Difluoromethoxyl-5,4'-di-n-octyl genistein inhibits the stem-like characteristics of gastric cancer stem-like cells and reverses the phenotype of epithelial-mesenchymal transition in gastric cancer cells.
    Cao X; Ren K; Song Z; Li D; Quan M; Zheng Y; Cao J; Zeng W; Zou H
    Oncol Rep; 2016 Aug; 36(2):1157-65. PubMed ID: 27279287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7-difluoromethoxyl-5,4'-di-n-octylgenistein inhibits growth of gastric cancer cells through downregulating forkhead box M1.
    Xiang HL; Liu F; Quan MF; Cao JG; Lv Y
    World J Gastroenterol; 2012 Sep; 18(33):4618-26. PubMed ID: 22969238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7-difluoromethoxyl-5,4'-di-n-octyl genistein inhibits ovarian cancer stem cell characteristics through the downregulation of FOXM1.
    Ning YX; Li QX; Ren KQ; Quan MF; Cao JG
    Oncol Lett; 2014 Jul; 8(1):295-300. PubMed ID: 24959264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of crosstalk between LX-2 and liver cancer stem-like cells from MHCC97H cells by DFOG via inhibiting FOXM1.
    Chen A; Xu C; Luo Y; Liu L; Song K; Deng G; Yang M; Cao J; Yuan L; Li X
    Acta Biochim Biophys Sin (Shanghai); 2019 Dec; 51(12):1267-1275. PubMed ID: 31750892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis induced by 7-difluoromethoxyl-5,4'-di-n-octyl genistein via the inactivation of FoxM1 in ovarian cancer cells.
    Ning Y; Li Q; Xiang H; Liu F; Cao J
    Oncol Rep; 2012 Jun; 27(6):1857-64. PubMed ID: 22447287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXO3a-mediated suppression of the self-renewal capacity of sphere-forming cells derived from the ovarian cancer SKOV3 cell line by 7-difluoromethoxyl-5,4'-di-n-octyl genistein.
    Ning Y; Luo C; Ren K; Quan M; Cao J
    Mol Med Rep; 2014 May; 9(5):1982-8. PubMed ID: 24604613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of AKT, ERK and NF-κB by genistein derivative, 7-difluoromethoxyl-5,4'-di-n-octylygenistein, reduces ovarian carcinoma oncogenicity.
    Ning Y; Xu M; Cao X; Chen X; Luo X
    Oncol Rep; 2017 Aug; 38(2):949-958. PubMed ID: 28627607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of FoxM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells.
    Bao B; Wang Z; Ali S; Kong D; Banerjee S; Ahmad A; Li Y; Azmi AS; Miele L; Sarkar FH
    J Cell Biochem; 2011 Sep; 112(9):2296-306. PubMed ID: 21503965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
    Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C
    Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling.
    Su J; Wu S; Wu H; Li L; Guo T
    Mol Carcinog; 2016 Dec; 55(12):1962-1973. PubMed ID: 26621583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein attenuates cancer stem cell characteristics in gastric cancer through the downregulation of Gli1.
    Yu D; Shin HS; Lee YS; Lee D; Kim S; Lee YC
    Oncol Rep; 2014 Feb; 31(2):673-8. PubMed ID: 24297371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin.
    Quan MF; Xiao LH; Liu ZH; Guo H; Ren KQ; Liu F; Cao JG; Deng XY
    World J Gastroenterol; 2013; 19(43):7680-95. PubMed ID: 24431896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing transcription factor FOXM1 represses proliferation, migration, and invasion while inducing apoptosis of liver cancer stem cells by regulating the expression of ALDH2.
    Chen L; Wu M; Ji C; Yuan M; Liu C; Yin Q
    IUBMB Life; 2020 Feb; 72(2):285-295. PubMed ID: 31580537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.
    Han M; Wang Y; Liu M; Bi X; Bao J; Zeng N; Zhu Z; Mo Z; Wu C; Chen X
    Cancer Sci; 2012 Jun; 103(6):1058-64. PubMed ID: 22435731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells.
    Bao B; Wang Z; Ali S; Kong D; Li Y; Ahmad A; Banerjee S; Azmi AS; Miele L; Sarkar FH
    Cancer Lett; 2011 Aug; 307(1):26-36. PubMed ID: 21463919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of β-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters.
    Li J; Zhou BP
    BMC Cancer; 2011 Feb; 11():49. PubMed ID: 21284870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soy Isoflavone Genistein Impedes Cancer Stemness and Mesenchymal Transition in Head and Neck Cancer through Activating miR-34a/RTCB Axis.
    Hsieh PL; Liao YW; Hsieh CW; Chen PN; Yu CC
    Nutrients; 2020 Jun; 12(7):. PubMed ID: 32610494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-598 inhibits the growth and maintenance of gastric cancer stem-like cells by down-regulating RRS1.
    Ma Y; Yan F; Wei W; Deng J; Li L; Liu L; Sun J
    Cell Cycle; 2019 Oct; 18(20):2757-2769. PubMed ID: 31438772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of FoxM1 leads to the inhibition of the epithelial-mesenchymal transition in gastric cancer cells.
    Miao L; Xiong X; Lin Y; Cheng Y; Lu J; Zhang J; Cheng N
    Cancer Genet; 2014 Mar; 207(3):75-82. PubMed ID: 24726291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrichment of cancer stem-like cells by the induction of epithelial-mesenchymal transition using lentiviral vector carrying E-cadherin shRNA in HT29 cell line.
    Saltanatpour Z; Johari B; Alizadeh A; Lotfinia M; Majidzadeh-A K; Nikbin B; Kadivar M
    J Cell Physiol; 2019 Dec; 234(12):22935-22946. PubMed ID: 31111504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.